Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 1,790 | 1,026 | 2,178 | 486 | 1,477 |
| Gross Profit | 1,790 | 1,026 | 2,178 | 486 | 1,477 |
| Operating Expenses | 35,229 | 33,397 | 34,928 | 31,467 | 33,527 |
| Operating Income | -33,439 | -32,371 | -32,750 | -30,981 | -32,050 |
| Other Income | 755 | 391 | 391 | 807 | 229 |
| Pre-tax Income | -32,684 | -31,980 | -32,359 | -30,174 | -31,821 |
| Net Income Continuous | -32,684 | -31,980 | -32,359 | -30,174 | -31,821 |
| Net Income | $-32,684 | $-31,980 | $-32,359 | $-30,174 | $-31,821 |
| EPS Basic Total Ops | -4.95 | -4.80 | -4.95 | -4.95 | -5.40 |
| EPS Basic Continuous Ops | -4.97 | -4.86 | -4.93 | -4.89 | -5.33 |
| EPS Diluted Total Ops | -4.95 | -4.80 | -4.95 | -4.95 | -5.40 |
| EPS Diluted Continuous Ops | -4.97 | -4.86 | -4.93 | -4.89 | -5.33 |
| EBITDA(a) | $-31,488 | $-30,624 | $-31,793 | $-31,275 | $-30,324 |